Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…
Semaglutide
Read More
Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Dr Reddy’s Plans Up to 60% Cheaper Generic Version of Wegovy as Patent Nears Expiry
India’s Dr Reddy’s Laboratories is preparing to introduce a significantly lower-priced generic version of blockbuster weight-loss drug Wegovy, currently sold…
Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Eli Lilly Prepares to Launch Obesity and Diabetes Drug Tirzepatide in India by 2025
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Semaglutide: Transform Your Health with Powerful Weight Loss and Heart Benefits
Semaglutide: A Dual Benefit for Heart Health and Weight Loss, but Potential Gut Issues Ahead semaglutide has emerged as a…
“Semaglutide Breakthrough: A Promising Solution for Treating Chronic Skin Condition in Obese Patients!”
Semaglutide, a medication initially developed for the treatment of type 2 diabetes and obesity, is now showing promising results in…